• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Nov. 15 deadline for Pediatric Cataract Initiative grant application


The American Medical Association (AMA) has published a new Current Procedural Terminology (CPT) code that applies to a proprietary osmolarity test (TearLab),

Chicago-Nov. 15 is the deadline for receipt of the Pediatric Cataract Initiative inaugural research grant applications.

One qualified individual, institution, or organization investigating the causes of pediatric cataract and/or improved treatment tools and protocols will receive $75,000.

The grant will support research that can be carried out in 12 months with limited resources. It is not geography-dependent, although the research should have a degree of applicability regionally or globally, according to the organization. Applicants may submit more than one proposal, provided that each is scientifically distinct. Interested parties may visit www.pediatriccataract.org/grant_funding to download the complete request for proposals.

The initiative is a partnership between the Bausch + Lomb Early Vision Institute and the Lions Clubs International Foundation. In addition to its non-geography-specific research grant, the initiative is committing funding and support during its first year to innovative, scalable prevention and treatment programs in the People’s Republic of China, where at least 40,000 children are estimated to have pediatric cataract.

Related Videos
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.